« Return to News | Awards & Advancement

Mymetics ropes in Dendreon vets

Wednesday, April 11, 2012 12:58 PM

Mymetics, a Swiss-based biotech of mucosal and virosomal-based vaccines for infectious diseases, has appointed Grant E. Pickering as president and CEO and Christopher S. Henney as chairman of the board of directors. The changes were made in connection with Mymetics’ efforts to obtain additional financing and to advance the development of its vaccine platform.

Grant E. Pickering, MBA, currently serves as executive-in-residence at Kleiner Perkins Caufield & Byers, a venture capital firm located in Menlo Park, Calif. He has previously served as president and CEO of Juvaris BioTherapeutics and Pharmada, as well as in managing and development positions at Dendreon, Johnson & Johnson, GlaxoSmithKline and Algos Pharmaceutical.

Christopher S. Henney, Ph.D., D.Sc., currently serves as chairman of the board of directors of Oncothyreon and Anthera Pharmaceuticals, and vice-chairman of the board of directors of Cyclacel Pharmaceuticals—all development-stage biotechnology companies. Previously, he served as chairman and CEO of Dendreon, chairman of SGX Pharmaceuticals and co-founded both Immunex and ICOS.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.